TriviumVet’s felycin®-CA1 has been granted conditional approval by the U.S. Food and Drug Administration (FDA). This marks a significant milestone in feline cardiac care as the...
Irish veterinary pharmaceutical company achieves landmark regulatory milestone for a condition affecting hundreds of thousands of dogs worldwide, with full approval study now...